Session Description
This session will provide a comprehensive overview of the major guideline changes in differentiated thyroid cancer and implications for clinical practice. Key topics include revised risk stratification criteria, updated surgical recommendations, refined guidelines for radioactive iodine therapy, role of molecular markers, and new strategies for surveillance and long-term followup